STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)
← catalyst calendarNCT07122661 · readout in 254 d
Sponsored by Pfizer (industry) · PFE — their whole pipeline →. With The Kids Research Institute Australia on behalf of the Centre for Child Health Research, University of Western Australia.
Phase
—
Status
Active, not recruiting
Study type
Observational
Enrollment
1estimated
Sites
1
Country
Australia
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-08-11 | actual | When the study began enrolling |
| Primary completion | 2027-04-30 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2027-04-30 | estimated | The whole study's end, after follow-up |
| First posted | 2025-08-14 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-11-19 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Respiratory Syncytial Virus (RSV)
- Respiratory Syncytial Virus
- Lower Respiratory Tract Disease
- Respiratory Tract Diseases
- Acute Respiratory Illness (ARI)
Intervention
- Biological: ABRYSVO — also filed as RSVpreF, RSV Prefusion F
Primary outcome
what the primary-completion date above is the date OFEstimate vaccine effectiveness of ABRYSVO during pregnancy against RSV-positive lower respiratory tract disease hospitalisation among infants.
measured From birth through 6 months (0 to ≤180 days) of age.
Permalink · PFE's whole pipeline · Catalyst calendar · Every registered study · What changed